Market closedNon-fractional
Inhibrx Biosciences/INBX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Inhibrx Biosciences
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what they believe to be the most appropriate agonist function.
Ticker
INBX
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology
Headquarters
La Jolla, United States
Employees
173
Website
inhibrx.com
INBX Metrics
BasicAdvanced
$194M
Market cap
-
P/E ratio
-
EPS
-
Beta
-
Dividend rate
Price and volume
Market cap
$194M
Financial strength
Current ratio
0.369
Quick ratio
0.008
Long term debt to equity
-5.209
Total debt to equity
-24.865
Management effectiveness
Valuation
Growth
INBX Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
-100.00%
Net income
-$49M
-68.24%
Profit margin
0.00%
-100.00%
INBX News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Inhibrx Biosciences stock?
Inhibrx Biosciences (INBX) has a market cap of $194M as of July 27, 2024.
What is the P/E ratio for Inhibrx Biosciences stock?
The price to earnings (P/E) ratio for Inhibrx Biosciences (INBX) stock is 0 as of July 27, 2024.
Does Inhibrx Biosciences stock pay dividends?
No, Inhibrx Biosciences (INBX) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Inhibrx Biosciences dividend payment date?
Inhibrx Biosciences (INBX) stock does not pay dividends to its shareholders.
What is the beta indicator for Inhibrx Biosciences?
Inhibrx Biosciences (INBX) does not currently have a Beta indicator.
Buy or sell Inhibrx Biosciences stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.